• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Heparin Sodium Teva 25000 IU / 5 ml
    / Teva

    Active Ingredient
    Heparin Sodium 25000 IU / 5 ml

    Status in Israel

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft


    1 X 25000 IU / 5 ml

    not in the basket chart 27195


    Dosage must be individually adjusted. The dosage depends on the coagulation parameters, the nature and course of the disease, the patient’s response, adverse reactions, and the patient’s weight and age. Differences in sensitivity to heparin and a possible change in heparin tolerance during the course of treatment need to be considered. Prophylaxis of thromboembolism (low-dose treatment). Subcutaneous injection is recommended for the prophylaxis of thromboembolism. Pre-filled syringes with an appropriate dosage are available for this. General dose recommendation for the prophylaxis of thromboembolism: – Pre- and postoperative prophylaxis of thromboembolism preoperatively 5000-7500 IU subcutaneously approximately 2 hours before the operation. Postoperatively, depending on the risk of thrombosis, usually 5000 IU subcutaneously every 8-12 hours or 7500 IU subcutaneously every 12 hours until the patient is mobilized or until vitamin K antagonists have an adequate effect.
    Please refer to the license holder for further details.


    Prevention of thromboembolic disorders. As part of the treatment of venous and arterial thromboembolic disorders (including early treatment of heart attacks as well as unstable angina pectoris). For the anticoagulation in case of treatment or operation with extracorporeal circulation (e.g.heart-lung machine, hemodialysis).


    Hypersensitivity to the active substance heparin or to any of the excipients. Current or previous history of heparin-induced allergic thrombocytopenia (type 2). Disorders associated with a bleeding diathesis, e.g. thrombocytopenia, coagulopathies, severe hepatic, renal or pancreatic disorders.
    Disorders in which there is a suspected lesion of the vascular system, e.g. gastrointestinal ulcers, hypertension (>105 mm Hg diastolic), cerebral haemorrhage, trauma or surgical operations involving the central nervous system (CNS), eye operations, retinopathies, vitreous haemorrhage, aneurysm of the cerebral arteries, infectious endocarditis. Threatened miscarriage – Spinal anaesthesia, epidural anaesthesia, lumbar puncture – Organ lesions associated with a bleeding tendency. Use in preterm or newborn babies because of the benzyl alcohol content.

    Special Precautions

    Please refer to the license holder for further details.

    Merckle GmbH, Germany